Status:

COMPLETED

The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life

Lead Sponsor:

Akdeniz University Hospital

Conditions:

Chemotherapeutic Toxicity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study aims to evaluate the effect of home-based walking program on peripheral neuropathy, fatigue and quality of life in patients receiving taxane and platinum-based chemotherapy.

Detailed Description

The study was designed as a randomized controlled trial. This study will be carried out with a total of 88 cancer patients receiving taxane and platinum-based chemotherapy, 44 of whom were in the inte...

Eligibility Criteria

Inclusion

  • İnclusion Criteria
  • 18 Years and older (Adult, Older Adult )
  • Turkish speaking-understanding ability and literate.
  • Orientation (person, place, time)
  • Receiving taxane and platinum-based chemotherapy treatment (monotherapy or combined).
  • Receiving chemotherapy treatment for the first time.
  • The primary medical diagnosis is cancer (breast cancer, colorectal cancers and other cancers).
  • Not having health problems that prevent walking.
  • Agreeing to participate in the research.
  • Exclusion Criteria
  • Being bone and brain metastases
  • Being peripheral neuropathy due to reasons other than chemotherapy (such as chronic disease, diabetes mellitus, nutritional disorders)
  • Skin sensitivity on the hands and feet
  • Having cardiovascular, pulmonary, musculoskeletal, or psychological disorders that limit exercise or mobility
  • Being in another supportive program
  • Being in the very active category according to the "International Physical Activity Scale (IPAQ- Short Form)"
  • Being a severity of more than 4 points according to the "Modified Borg Scale (MBS)"
  • Being a score of 2 and above according to the "ECOG Performance Scale"

Exclusion

    Key Trial Info

    Start Date :

    September 15 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 20 2024

    Estimated Enrollment :

    88 Patients enrolled

    Trial Details

    Trial ID

    NCT06012253

    Start Date

    September 15 2023

    End Date

    December 20 2024

    Last Update

    June 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Akdeniz University

    Konyaalti, Antalya, Turkey (Türkiye), 07058